Mark highlights the bank’s successful...
hVIVO Omicron human challenge agent has been successfully manufactured
16th March 2023
hVIVO plc (LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has
